Alfred Deakin Professor Berk's research interests are predominantly in the area of novel therapy development. Research domains include mood disorders, particularly bipolar disorder and depression, schizophrenia and chronic fatigue syndrome. Other projects include internet therapies, drug safety, biomarkers and early intervention.